ANGELA JAMESON: Open Payments
NPI 1609470400 · MANSFIELD, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 10 payments from 6 companies in 2025. Trend: 2023 $111 · 2024 $76 · 2025 $165
Food & beverage: $163Education: $2
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Lilly USA, LLC | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| ABBVIE INC. | 2 | $34 |
| Dexcom, Inc. | 1 | $19 |
| Travere Therapeutics, Inc. | 1 | $2 |
Products named: CAPLYTA, JARDIANCE, GVOKE HYPOPEN, UBRELVY, Dexcom G6 Transmitter, Filspari.
Industry payments across OH — which companies pay providers there.
